ES2112844T3 - 4-(3-(4-oxotiazoldinil))butinilaminas, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

4-(3-(4-oxotiazoldinil))butinilaminas, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2112844T3
ES2112844T3 ES91105972T ES91105972T ES2112844T3 ES 2112844 T3 ES2112844 T3 ES 2112844T3 ES 91105972 T ES91105972 T ES 91105972T ES 91105972 T ES91105972 T ES 91105972T ES 2112844 T3 ES2112844 T3 ES 2112844T3
Authority
ES
Spain
Prior art keywords
sub
united
lower alkyl
independently hydrogen
taken together
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91105972T
Other languages
English (en)
Inventor
Nicholas J Hrib
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ES2112844T3 publication Critical patent/ES2112844T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA DONDE R SUB 1 Y R SUB 2 SON INDEPENDIENTEMENTE HIDROGENO O ALQUILO INFERIOR O R SUB 1 Y R SUB 2 TOMADOS JUNTO CON EL ATOMO DE CARBONO AL QUE ESTAN UNIDOS FORMAN UN CICLOALCANO CONDENSADO EN ESPIRAL DE 5 A 8 CARBONOS ; R SUB 3 Y R SUB 4 SON INDEPENDIENTEMENTE HIDROGENO O ALQUILO INFERIOR O R SUB 3 Y R SUB 4 TOMADOS JUNTO CON EL ATOMO DE CARBONO AL QUE ESTAN UNIDOS FORMAN UN CICLOALCANO CONDENSADO EN ESPIRAL DE 5 A 8 CARBONOS; R SUB 5 Y R SUB 6 TOMADOS JUNTO CON EL ATOMO DE NITROGENO AL QUE VAN UNIDOS SON DONDE X CADA VEZ QUE APARECE ES INDEPENDIENTEMENTE HIDROGENO, HALOGENO, ALQUILO INFERIOR, NITRO, AMINO, CIANO, TRIFLUOROMETILO O METOXI; Y M ES 0, 1 O 2; SUS SALES DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLES Y DONDE SEAN APLICABLES SUS ISOMEROS OPTICOS Y GEOMETRICOS Y MEZCLAS RACEMICAS. LOS COMPUESTOS DE ESTA INVENCION SON UTILES COMO AGENTES ANALGESICOS Y ANTIHIPERTENSIVOS.
ES91105972T 1990-04-16 1991-04-15 4-(3-(4-oxotiazoldinil))butinilaminas, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2112844T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/509,280 US5034392A (en) 1990-04-16 1990-04-16 4-(3-(4-oxothiazolidinyl)butynylamines

Publications (1)

Publication Number Publication Date
ES2112844T3 true ES2112844T3 (es) 1998-04-16

Family

ID=24025983

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91105972T Expired - Lifetime ES2112844T3 (es) 1990-04-16 1991-04-15 4-(3-(4-oxotiazoldinil))butinilaminas, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (26)

Country Link
US (1) US5034392A (es)
EP (1) EP0452850B1 (es)
JP (1) JPH07119223B2 (es)
KR (1) KR0163598B1 (es)
AR (1) AR248402A1 (es)
AT (1) ATE163010T1 (es)
AU (1) AU636972B2 (es)
BG (1) BG60066B2 (es)
CA (1) CA2040489C (es)
CZ (1) CZ284447B6 (es)
DE (1) DE69128845T2 (es)
DK (1) DK0452850T3 (es)
ES (1) ES2112844T3 (es)
FI (1) FI94755C (es)
GR (1) GR3026319T3 (es)
HU (1) HUT61017A (es)
IE (1) IE911257A1 (es)
IL (1) IL97852A (es)
MX (1) MX25359A (es)
NO (1) NO300134B1 (es)
NZ (1) NZ237811A (es)
PL (1) PL165488B1 (es)
PT (1) PT97371B (es)
RO (1) RO108683B1 (es)
RU (1) RU2001914C1 (es)
ZA (1) ZA912783B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273977A (en) * 1990-11-05 1993-12-28 Warner-Lambert Company Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
US5147881A (en) * 1990-11-14 1992-09-15 Pfizer Inc 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
US5194436A (en) * 1991-01-10 1993-03-16 Hoechst-Roussel Pharmaceuticals Inc. 1-piperazinyl-2-butenes and -2-butynes
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354178A (en) * 1965-04-09 1967-11-21 Sterling Drug Inc Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides
DE3875073T2 (de) * 1987-11-20 1993-03-11 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.

Also Published As

Publication number Publication date
NO300134B1 (no) 1997-04-14
JPH04234879A (ja) 1992-08-24
JPH07119223B2 (ja) 1995-12-20
HU911239D0 (en) 1991-10-28
KR0163598B1 (ko) 1998-12-01
PL289892A1 (en) 1992-07-27
PT97371B (pt) 1998-08-31
RO108683B1 (ro) 1994-07-29
MX25359A (es) 1994-05-31
CS9101065A2 (en) 1991-11-12
KR910018367A (ko) 1991-11-30
ATE163010T1 (de) 1998-02-15
AR248402A1 (es) 1995-08-18
NZ237811A (en) 1993-12-23
HUT61017A (en) 1992-11-30
IE911257A1 (en) 1991-10-23
AU636972B2 (en) 1993-05-13
ZA912783B (en) 1991-12-24
IL97852A0 (en) 1992-06-21
RU2001914C1 (ru) 1993-10-30
EP0452850B1 (en) 1998-02-04
NO911465D0 (no) 1991-04-15
FI911783A0 (fi) 1991-04-12
NO911465L (no) 1991-10-17
DK0452850T3 (da) 1998-09-23
PT97371A (pt) 1992-01-31
CZ284447B6 (cs) 1998-11-11
FI94755B (fi) 1995-07-14
AU7502891A (en) 1991-10-17
BG60066B2 (bg) 1993-09-30
FI911783A (fi) 1991-10-17
FI94755C (fi) 1995-10-25
GR3026319T3 (en) 1998-06-30
PL165488B1 (pl) 1994-12-30
IL97852A (en) 1994-11-28
EP0452850A1 (en) 1991-10-23
DE69128845T2 (de) 1998-07-09
US5034392A (en) 1991-07-23
CA2040489A1 (en) 1991-10-17
CA2040489C (en) 2003-06-10
DE69128845D1 (de) 1998-03-12

Similar Documents

Publication Publication Date Title
CU23148A3 (es) Compuestos azapoliciclicos condensados con arilo
UY26872A1 (es) Derivados de la 4- fenil piridina
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
PE20041040A1 (es) Compuestos derivados de amidas como inhibidores de 11-beta-hidroxiesteroide-deshidroxigenasa de tipo 1
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
CY1106276T1 (el) Παραγωγα υποκατεστημενου φαινυλπροπιονικου οξεος ως ανταγωνιστες σε υποδοχεις αλφα που ενepγοποιουνται απο παραγοντες που επαγουν τον πολλαπλασιασμο των ανθρωπινων υπepοξεισωματων (ppar)
ECSP034744A (es) Antagonistas de nmda/nr2b no arilo-heterociclico n-sustituidos
PA8575401A1 (es) Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso
ES2112830T3 (es) 4-pirimidinaminas y -pirimidindiaminas sustituidas en n, un procedimiento para su preparacion y su uso como medicamentos.
ECSP024399A (es) Derivados de benzotiazol
SV2002000047A (es) Procedimientos e intermedios para preparar compuestos anticancerosos ref.pc10188 abcz
PA8654501A1 (es) Derivados de quinazolina inhibidores de quinasas dirigidos a multiples blancos
AR015712A1 (es) Derivados de 3,4-dihidro-tieno[2,3-d]pirimidina-3-sustituidos y su uso para la preparacion de composiciones farmaceuticas
ES2127524T3 (es) Derivados de benzamida como antagonistas de vasopresina.
ES2178205T3 (es) Compuestos amida indazol como agentes serotoninergicos.
PA8589601A1 (es) Derivados de indazol como antagonistas del crf
CO5011069A1 (es) Procedimiento para la preparacion de acidos 8-metoxiquinolon carboxilicos
PA8463001A1 (es) Compuestos de eteres ciclicos de piperidinilaminometil trifluorometilo como antagonistas de la sustancia p
UY27786A1 (es) Derivados de isoquinolina.
SV2004001416A (es) Compuestos azapoliciclicos condensados con arilo ref. pc23246
ID23954A (id) Tetrahidrogama-karbolin
ES2094742T3 (es) Aminocarbonilcarbamatos relacionados con fisostigmina, un procedimiento para su preparacion y su uso como medicamentos.
PA8534001A1 (es) Derivados de piperazina 1,4-disustituida utiles como bloqueadores alfa1,-adrenoceptores uro-selectivos
AR007088A1 (es) 2,4-diaminopirimidinas sustituidas, compuestos intermedios utilizados en su preparacion, procedimiento para la preparacion de dichas 2,4-diaminopirimidinas sustituidas, medicamentos que las contienen y empleos de dichas pirimidinas
PA8589801A1 (es) Aminoalcoxiindoles

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 452850

Country of ref document: ES